Cargando…

Clinical profile of children with West syndrome: A retrospective chart review

BACKGROUND: This study was intended to document the clinical profile and treatment outcome of West syndrome in children attending a tertiary care centre in Northern India. METHODS: Data were collected by a retrospective chart review of children diagnosed with West syndrome between January 2017 to Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehlawat, Virender K., Arya, Vandana, Bhardwaj, Harish, Vaswani, Narain D., Kaushik, Jaya S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132827/
https://www.ncbi.nlm.nih.gov/pubmed/34017752
http://dx.doi.org/10.4103/jfmpc.jfmpc_1405_20
_version_ 1783694968162877440
author Gehlawat, Virender K.
Arya, Vandana
Bhardwaj, Harish
Vaswani, Narain D.
Kaushik, Jaya S.
author_facet Gehlawat, Virender K.
Arya, Vandana
Bhardwaj, Harish
Vaswani, Narain D.
Kaushik, Jaya S.
author_sort Gehlawat, Virender K.
collection PubMed
description BACKGROUND: This study was intended to document the clinical profile and treatment outcome of West syndrome in children attending a tertiary care centre in Northern India. METHODS: Data were collected by a retrospective chart review of children diagnosed with West syndrome between January 2017 to January 2018. Information was recorded pertaining to the age at onset and presentation, etiology, and associated co-morbidities; results of electroencephalography (EEG) and neuroimaging; treatment given; and final outcome. The following drugs were used for treatment: ACTH (n = 7), prednisolone (n = 17), vigabatrin (n = 25), sodium valproate (n = 28), clonazepam (n = 30), and levetiracetam (n = 13) and modified Atkins diet (n = 7). The response was categorized as spasm cessation, partial improvement (>50% improvement), or no improvement. RESULTS: Records of 30 children (21 boys) were analyzed. The median (IQR) age at onset was 4 (3, 6.5) months. The median (IQR) lag time to treatment was 5 (2,14) months. Eight (26%) were premature, 2 (7%) were small for gestational age, birth asphyxia in 56%, neonatal encephalopathy in 62%. EEG findings were hypsarrhythmia in 13 (43.3%) children and modified hypsarrhythmia in 9 (30%) children. MRI finding was periventricular leukomalacia (54.1%), cystic encephalomalacia (13.8%), normal MRI (20.7%) and one had arrested hydrocephalus. There was no improvement with valproate (93%), clonazepam (89%), levetiracetam (78%). Cessation of spasm was achieved with vigabatrin (28%), prednisolone (38.2%), ACTH (42.8%). Hypsarrhythmia resolved with improvement in of background and other epileptiform abnormalities in 17 children. CONCLUSION: The present research highlights favourable response of West syndrome to oral steroids, vigabatrin and ACTH with limited role of conventional antiepileptic drugs like sodium valporate, levetiracetam and clonazepam. Primary care physician plays a vital role in early recognition and treatment of epileptic spasm.
format Online
Article
Text
id pubmed-8132827
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81328272021-05-19 Clinical profile of children with West syndrome: A retrospective chart review Gehlawat, Virender K. Arya, Vandana Bhardwaj, Harish Vaswani, Narain D. Kaushik, Jaya S. J Family Med Prim Care Original Article BACKGROUND: This study was intended to document the clinical profile and treatment outcome of West syndrome in children attending a tertiary care centre in Northern India. METHODS: Data were collected by a retrospective chart review of children diagnosed with West syndrome between January 2017 to January 2018. Information was recorded pertaining to the age at onset and presentation, etiology, and associated co-morbidities; results of electroencephalography (EEG) and neuroimaging; treatment given; and final outcome. The following drugs were used for treatment: ACTH (n = 7), prednisolone (n = 17), vigabatrin (n = 25), sodium valproate (n = 28), clonazepam (n = 30), and levetiracetam (n = 13) and modified Atkins diet (n = 7). The response was categorized as spasm cessation, partial improvement (>50% improvement), or no improvement. RESULTS: Records of 30 children (21 boys) were analyzed. The median (IQR) age at onset was 4 (3, 6.5) months. The median (IQR) lag time to treatment was 5 (2,14) months. Eight (26%) were premature, 2 (7%) were small for gestational age, birth asphyxia in 56%, neonatal encephalopathy in 62%. EEG findings were hypsarrhythmia in 13 (43.3%) children and modified hypsarrhythmia in 9 (30%) children. MRI finding was periventricular leukomalacia (54.1%), cystic encephalomalacia (13.8%), normal MRI (20.7%) and one had arrested hydrocephalus. There was no improvement with valproate (93%), clonazepam (89%), levetiracetam (78%). Cessation of spasm was achieved with vigabatrin (28%), prednisolone (38.2%), ACTH (42.8%). Hypsarrhythmia resolved with improvement in of background and other epileptiform abnormalities in 17 children. CONCLUSION: The present research highlights favourable response of West syndrome to oral steroids, vigabatrin and ACTH with limited role of conventional antiepileptic drugs like sodium valporate, levetiracetam and clonazepam. Primary care physician plays a vital role in early recognition and treatment of epileptic spasm. Wolters Kluwer - Medknow 2021-01 2021-01-30 /pmc/articles/PMC8132827/ /pubmed/34017752 http://dx.doi.org/10.4103/jfmpc.jfmpc_1405_20 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Gehlawat, Virender K.
Arya, Vandana
Bhardwaj, Harish
Vaswani, Narain D.
Kaushik, Jaya S.
Clinical profile of children with West syndrome: A retrospective chart review
title Clinical profile of children with West syndrome: A retrospective chart review
title_full Clinical profile of children with West syndrome: A retrospective chart review
title_fullStr Clinical profile of children with West syndrome: A retrospective chart review
title_full_unstemmed Clinical profile of children with West syndrome: A retrospective chart review
title_short Clinical profile of children with West syndrome: A retrospective chart review
title_sort clinical profile of children with west syndrome: a retrospective chart review
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132827/
https://www.ncbi.nlm.nih.gov/pubmed/34017752
http://dx.doi.org/10.4103/jfmpc.jfmpc_1405_20
work_keys_str_mv AT gehlawatvirenderk clinicalprofileofchildrenwithwestsyndromearetrospectivechartreview
AT aryavandana clinicalprofileofchildrenwithwestsyndromearetrospectivechartreview
AT bhardwajharish clinicalprofileofchildrenwithwestsyndromearetrospectivechartreview
AT vaswaninaraind clinicalprofileofchildrenwithwestsyndromearetrospectivechartreview
AT kaushikjayas clinicalprofileofchildrenwithwestsyndromearetrospectivechartreview